Literature DB >> 19878354

Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells.

Emanuela Greco1, Marilina B Santucci, Michela Sali, Francesca R De Angelis, Massimiliano Papi, Marco De Spirito, Giovanni Delogu, Vittorio Colizzi, Maurizio Fraziano.   

Abstract

Human alveolar epithelial cells actively contribute to the innate immune response in the lung and play an important role in mycobacterial dissemination during primary infection, by undergoing cell death and by releasing mycobacteria. In the present study, we report that natural lysophospholipids, such as lysophosphatidic acid or sphingosine 1-phosphate, reduce Mycobacterium tuberculosis-induced cytotoxicity and enhance anti-mycobacterial activity in the A549 cell line, used as a model of type II alveolar epithelial cells. Intracellular mycobacterial killing was strictly dependent on phagolysosome maturation, which in turn was promoted by the activation of a Ca(2+)dependent phospholipase D. Finally, the restriction of mycobacteria in highly microbiocidal compartments was associated, in vitro, with a significant decrease in mycobacterial dissemination to macrophages. Taken as whole, these results suggest that the pulmonary lysophospholipid microenvironment may play a protective role during the early phases of host-pathogen interaction by enhancing anti-mycobacterial activity in type II alveolar epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878354      PMCID: PMC2807493          DOI: 10.1111/j.1365-2567.2009.03145.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

Review 1.  Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting.

Authors:  Y C Manabe; W R Bishai
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

2.  TB comes to a sticky beginning.

Authors:  D G Russell
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

Review 3.  Innate immunity and pulmonary host defense.

Authors:  P Zhang; W R Summer; G J Bagby; S Nelson
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

Review 4.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

Review 5.  Correlates of protective immunity to Mycobacterium tuberculosis in humans.

Authors:  J J Ellner; C S Hirsch; C C Whalen
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079

6.  Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.

Authors:  R Hernández-Pando; M Jeyanathan; G Mengistu; D Aguilar; H Orozco; M Harboe; G A Rook; G Bjune
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

7.  ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion.

Authors:  I P Fairbairn; C B Stober; D S Kumararatne; D A Lammas
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

8.  Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.

Authors:  Ann Mander; Simon Langton-Hewer; Wolfgang Bernhard; John O Warner; Anthony D Postle
Journal:  Am J Respir Cell Mol Biol       Date:  2002-12       Impact factor: 6.914

9.  Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria.

Authors:  Elsa Anes; Mark Philipp Kühnel; Evelyne Bos; Jose Moniz-Pereira; Anja Habermann; Gareth Griffiths
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

10.  Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells.

Authors:  Lia Danelishvili; Jeffery McGarvey; Yong-Jun Li; Luiz E Bermudez
Journal:  Cell Microbiol       Date:  2003-09       Impact factor: 3.715

View more
  11 in total

1.  Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection.

Authors:  Emanuela Greco; Gianluca Quintiliani; Marilina B Santucci; Annalucia Serafino; Anna Rita Ciccaglione; Cinzia Marcantonio; Massimiliano Papi; Giuseppe Maulucci; Giovanni Delogu; Angelo Martino; Delia Goletti; Loredana Sarmati; Massimo Andreoni; Alfonso Altieri; Mario Alma; Nadia Caccamo; Diana Di Liberto; Marco De Spirito; Nigel D Savage; Roberto Nisini; Francesco Dieli; Tom H Ottenhoff; Maurizio Fraziano
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

2.  Epithelial-mesenchymal co-culture model for studying alveolar morphogenesis.

Authors:  Rachel M Greer; J Davin Miller; Victor O Okoh; Brian A Halloran; Lawrence S Prince
Journal:  Organogenesis       Date:  2014-10-31       Impact factor: 2.500

3.  Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  Travis McQuiston; Chiara Luberto; Maurizio Del Poeta
Journal:  Microbiology (Reading)       Date:  2011-02-03       Impact factor: 2.777

Review 4.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

5.  Monosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against Tuberculosis.

Authors:  Francesco Taus; Marilina B Santucci; Emanuela Greco; Matteo Morandi; Ivana Palucci; Sabrina Mariotti; Noemi Poerio; Roberto Nisini; Giovanni Delogu; Maurizio Fraziano
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

6.  Toxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKCα.

Authors:  Hyun-Jung Koh; Ye-Ram Kim; Jae-Sung Kim; Jin-Seung Yun; Kiseok Jang; Chul-Su Yang
Journal:  PLoS Pathog       Date:  2017-01-26       Impact factor: 6.823

7.  Liposomes loaded with bioactive lipids enhance antibacterial innate immunity irrespective of drug resistance.

Authors:  Noemi Poerio; Francesca Bugli; Francesco Taus; Marilina B Santucci; Carlo Rodolfo; Francesco Cecconi; Riccardo Torelli; Francesco Varone; Riccardo Inchingolo; Fabio Majo; Vincenzina Lucidi; Sabrina Mariotti; Roberto Nisini; Maurizio Sanguinetti; Maurizio Fraziano
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

8.  Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans.

Authors:  Fengling Luo; Xiaoming Sun; Yubin Wang; Qilong Wang; Yanhong Wu; Qin Pan; Chao Fang; Xiao-Lian Zhang
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

9.  PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2.

Authors:  Ivana Palucci; Serena Camassa; Alessandro Cascioferro; Michela Sali; Saber Anoosheh; Antonella Zumbo; Mariachiara Minerva; Raffaella Iantomasi; Flavio De Maio; Gabriele Di Sante; Francesco Ria; Maurizio Sanguinetti; Giorgio Palù; Michael J Brennan; Riccardo Manganelli; Giovanni Delogu
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

Review 10.  The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.

Authors:  Roberto Nisini; Noemi Poerio; Sabrina Mariotti; Federica De Santis; Maurizio Fraziano
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.